Home Medicines Review: what it is, and the claims angle
Australia already funds whole-of-regimen pharmacist reviews. Claims teams can't order one — but they can make the case for one, with evidence.
A Home Medicines Review (HMR) is a Medicare-funded clinical service: on GP referral, an accredited pharmacist reviews all of a patient's medicines — usually at home — and reports back to the GP with findings and recommendations. On injury claims it is a legitimate, under-used way to get a claimant's whole regimen clinically reviewed.
Key Takeaways
- What it is: a GP-referred, Medicare-funded medication review by an accredited pharmacist, typically in the patient’s home
- Who it’s for: patients at risk of medication misadventure — polypharmacy, high-risk medicines, multiple prescribers; many injured workers qualify on any of these
- The output: a pharmacist report to the referring GP with findings and recommendations; the GP agrees a medication management plan with the patient
- The claims angle: when a claim’s regimen is the problem, suggesting the treating GP consider an HMR is a clinically respectful escalation path
- Not an insurer tool: HMRs run through the GP and patient — insurers don’t commission them; they can only make the case for one
How the program works
- GP referral: the treating GP identifies medication-misadventure risk and refers
- Pharmacist review: an accredited pharmacist reviews every medicine — prescribed and otherwise — usually at the patient's home, where the reality of use is visible
- Report to the GP: findings and recommendations: interactions, duplication, adherence, simplification and deprescribing candidates
- Medication management plan: the GP and patient agree what changes
Program details and eligibility are published by the Department of Health and the Pharmacy Programs Administrator; accredited pharmacists conduct the reviews.
Using it from the claims side — properly
The claims team's lever is evidence, not authority. When the claims-side review shows a regimen working against the claim — polypharmacy, sedative stacking, multi-prescriber duplication — a letter to the treating GP that presents the reconciled history and suggests an HMR is a clinically respectful escalation: it hands the problem to the right clinician with the evidence attached, funded by a program that exists for exactly this patient.
Related vocabulary: pharmacist medication review (the broader discipline), polypharmacy review, and deprescribing.
See what a complete medication picture looks like on a claim
Allmeds produces the evidence that makes the HMR suggestion land: the reconciled history and the specific concerns, drafted into a letter to the treating GP.
Related pages
Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.